Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Biernacka

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Translational Psychiatry|September 12, 2017
Association of the serotonin transporter-linked polymorphic region genotype with lower bone mineral densityM I Lapid, S Kung, M A Frye, et al.
Molecular Psychiatry|December 11, 2013
Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2S J Winham, A B Cuellar-Barboza, A Oliveros, et al.
Translational Psychiatry|December 10, 2015
Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disordersM A Frye, M Nassan, G D Jenkins, et al.
Translational Psychiatry|August 17, 2016
Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbiditiesM L Prieto, E Ryu, G D Jenkins, et al.
Acta Psychiatrica Scandinavica|April 27, 2020
Evening chronotype, disordered eating behavior, and poor dietary habits in bipolar disorderF Romo-Nava, T J Blom, A Guerdjikova, et al.
Translational Psychiatry|October 11, 2012
Using a pharmacogenomic algorithm to guide the treatment of depressionD K Hall-Flavin, J G Winner, J D Allen, et al.
Translational Psychiatry|August 19, 2015
Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjectsH W Nam, V M Karpyak, D J Hinton, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 12, 2008
SLC6A4 variation and citalopram responseD A Mrazek, A J Rush, J M Biernacka, et al.
The Pharmacogenomics Journal|August 22, 2012
Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomicsY Ji, J M Biernacka, S Hebbring, et al.
Translational Psychiatry|October 8, 2014
Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosateV M Karpyak, J M Biernacka, J R Geske, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Translational Psychiatry|September 12, 2017
Association of the serotonin transporter-linked polymorphic region genotype with lower bone mineral densityM I Lapid, S Kung, M A Frye, et al.
Molecular Psychiatry|December 11, 2013
Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2S J Winham, A B Cuellar-Barboza, A Oliveros, et al.
Translational Psychiatry|December 10, 2015
Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disordersM A Frye, M Nassan, G D Jenkins, et al.
Translational Psychiatry|August 17, 2016
Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbiditiesM L Prieto, E Ryu, G D Jenkins, et al.
Acta Psychiatrica Scandinavica|April 27, 2020
Evening chronotype, disordered eating behavior, and poor dietary habits in bipolar disorderF Romo-Nava, T J Blom, A Guerdjikova, et al.
Translational Psychiatry|October 11, 2012
Using a pharmacogenomic algorithm to guide the treatment of depressionD K Hall-Flavin, J G Winner, J D Allen, et al.
Translational Psychiatry|August 19, 2015
Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjectsH W Nam, V M Karpyak, D J Hinton, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 12, 2008
SLC6A4 variation and citalopram responseD A Mrazek, A J Rush, J M Biernacka, et al.
The Pharmacogenomics Journal|August 22, 2012
Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomicsY Ji, J M Biernacka, S Hebbring, et al.
Translational Psychiatry|October 8, 2014
Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosateV M Karpyak, J M Biernacka, J R Geske, et al.
Pageof 2